William D. Thomas - Concepedia

Concepedia

Author

William D. Thomas

University of Massachusetts Chan Medical School

Also Known As

Thomas Jr., William D., Thomas, William D., W D Thomas, W Thomas, W. D. Thomas, W. Thomas, W.D. Thomas, William D Thomas, William D Thomas Jr, William D. Thomas

85

Publications

5.6K

Citations

29

H-Index

90

Concepts

All Affiliations

University of Massachusetts Chan Medical School University of Wisconsin–Madison Centers for Disease Control and Prevention University of Maryland, Baltimore University of Missouri

WD

About

William D. Thomas is an author at University of Massachusetts Chan Medical School specializing in medicine, immunology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	2.2K
2	Natural Sciences	5	5	212
3	Health Sciences	3	3	348
4	Engineering	2	2	502
5	Allergy	1	1	43

William D. Thomas

×

40

Publications

5.6K

Citations

29

H-Index

	Year	Citations
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination Marie Scully, Deepak Singh, Robert Lown, New England Journal of Medicine	2021	981
Treatment with Monoclonal Antibodies against <i>Clostridium difficile</i> Toxins Israel Lowy, Deborah C. Molrine, Brett Leav, New England Journal of Medicine	2010	738
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus Scott A. Jeffers, Sonia M. Tusell, Laura Gillim-Ross, Proceedings of the National Academy of Sciences	2004	627
Surface Plasmon Resonance Imaging Studies of Protein-Carbohydrate Interactions Emily A. Smith, William D. Thomas, Laura L. Kiessling, Journal of the American Chemical Society EngineeringPolysaccharideProtein NanoparticlesBiosensing SystemsBioanalysis	2003	485
Human Monoclonal Antibodies Directed against Toxins A and B Prevent <i>Clostridium difficile</i> -Induced Mortality in Hamsters Gregory J. Babcock, Teresa J. Broering, Héctor J. Hernández, Infection and Immunity Microbial ToxinHealth SciencesMicrobial PathogensToxinologyImmunotoxicology	2006	254
Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor Gregory J. Babcock, Diana J. Esshaki, William D. Thomas, Journal of Virology Virus StructureMolecular VirologyAmino AcidsSynthetic VirologyRespiratory Diseases	2004	245
Oral Immunization with Recombinant Helicobacter pylori Urease Induces Secretory IgA Antibodies and Protects Mice from Challenge with Helicobacter felis C K Lee, Richard Weltzin, William D. Thomas, The Journal of Infectious Diseases Protects MiceMedicinePathogenesisImmunologyGastroenterology	1995	218
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus Teresa J. Broering, Kerry A. Garrity, Naomi K. Boatright, Journal of Virology Hepatitis C VirusImmunologyViral Structural ProteinImmunotherapyVirus Structure	2009	181
Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice Thomas C. Greenough, Gregory J. Babcock, Anjeanette Roberts, The Journal of Infectious Diseases	2005	160
Safety and Immunogenicity of Increasing Doses of a <i>Clostridium difficile</i> Toxoid Vaccine Administered to Healthy Adults Karen L. Kotloff, Steven S. Wasserman, Genevieve A. Losonsky, Infection and Immunity	2001	155

Page 1